BSD Medical will host an Investor & Analyst Update Call and live webcast on Wednesday, March 6, 2013, at 2:00 p.m. (see below).
The company has been having success with an innovative, recently-introduced marketing plan – a fee-per-use plan (FPU) -- for their MTX-180 microwave tumor-ablation product. This is an important, major advance (from reports by leading Interventional Oncology doctors), but capital expenditures by hospitals are still heavily curtailed (due to the recession), so the commonly slow market introduction for medical devices had been even slower for the MTX-180. The FPU plan for the MTX-180 was implemented to overcome this lack of capital spending.
Since the MTX-180 is small and light (only 40#, with the rolling cart removed), it can easily be delivered for one-time use – and a “handsome” fee is charged. The company has revealed that as few as three FPUs pay for the mfg costs! Also, the up-to-three disposable “antennas” used for each procedure sell for about $2000 each! The MTX-180 is potentially highly profitable; even with modest market penetration – which market addressed is very substantial and rapidly growing.
The MTX-180 is also available for long-term leases and outright sales – but the FPU plan has, so far, been most successful. And, the FPU plan provides for easy clinical trials by pioneering doctors.
The company has other products that are also seeing growth worldwide, as hyperthermia therapy and tumor ablation are becoming accepted practices. BSD Medical is the clear world leader in this major advance in cancer therapy – a therapy that is widely applicable to various tumors while lacking the serious side effects of surgery, radiotherapy, and chemotherapy (and all three of these established therapies are much potentiated when hyperthermia is combined with them as an adjunct).
This is a CC worth listening carefully to:
http://investor.bsdmedical.com/press-release/results-operations-and-corporate-announcements/bsd-medical-corporation-announces-inv-0
SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that it will host an Investor & Analyst Update Call and live webcast on Wednesday, March 6, 2013, at 2:00 p.m. Eastern time/12:00 p.m. Mountain time. The call will be hosted by Harold Wolcott, President, and William Barth, CFO.
Individuals interested in participating in the conference call may do so by visiting the Investor Relations section of the Company's website at www.BSDMedical.com or by dialing 800-762-8779 from the United States, or 480-629-9645 from outside the United States, and entering conference ID 4602120. We request that you RSVP to the conference call by emailing tross@finprofiles.com before 4:00 p.m. Eastern time on Monday, March 4, 2013. |
